Updated CHEST Guidelines on Antithrombotic Therapy in Venous Thromboembolism
The updated CHEST guideline on antithrombotic therapy for VTE includes 4 new PICO questions as well as updated recommendations based on newer evidence.
All articles by Brandon May
Does Amoxicillin Benefit Children With Lower Respiratory Tract Infections?
Does the prescription of antibiotics provide a meaningful clinical benefit for children who present with uncomplicated lower respiratory tract infections?
Modifiable Risk Factors and Cognitive Impairment in Patients With Psoriasis
Potential risk factors associated with cognitive impairment in patients with psoriasis are assessed.
Secukinumab vs Adalimumab in Concomitant PsA and Plaque Psoriasis
Secukinumab vs adalimumab for treatment in patients with concomitant plaque psoriasis and active psoriatic arthritis during 52 weeks is reported.
SGLT2 Inhibitors Lead to Favorable Renal, CV Outcomes in Type 2 Diabetes
Using certain glucose inhibitors in people with type 2 diabetes may also have a beneficial effect on renal and cardiovascular health, and weight.
Increased Dietary Intake of L-Arginine Linked to Increased Risk for Type 2 Diabetes
Researchers studied the effect of dietary L-arginine on the incidence of type 2 diabetes.
Baseline Cytokine Levels May Predict Patients’ Response to Benralizumab in Severe Asthma
Patients with severe asthma with low baseline cytokine levels responded well to benralizumab therapy.
Approaches to Reduce Therapeutic Inertia in Diabetes Management
A team of researchers investigated the effect of interventions to overcome therapeutic inertia regarding glycemic control in patients with type 2 diabetes.
AHA Releases Scientific Statement on Sleep-Disordered Breathing and Cardiovascular Disease
The AHA outlines screening, diagnosis, and treatment recommendations for obstructive sleep apnea and CV complications tied to the sleep disorder.
Guselkumab Shows Skin Clearance in Psoriasis, Joint Symptom Improvement in Psoriatic Arthritis
At AAD VMX 2021, researchers presented data on skin clearance rates through 5 years with guselkumab in patients with moderate to severe plaque psoriasis.
- Loading...
Loading...
Next post in Dermatology Information Center
Loading... 
Loading...